OrbiMed’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,928,900
| Closed | -$6.85K | – | 133 |
|
|
2022
Q3 | $6.85K | Hold |
2,928,900
| – | – | 0.13% | 97 |
|
|
2022
Q2 | $8.88K | Buy |
2,928,900
+69,000
| +2% | +$209 | 0.16% | 96 |
|
|
2022
Q1 | $19.4M | Hold |
2,859,900
| – | – | 0.31% | 66 |
|
|
2021
Q4 | $23.9M | Buy |
2,859,900
+204,300
| +8% | +$1.71M | 0.31% | 79 |
|
|
2021
Q3 | $19.7M | Buy |
2,655,600
+508,200
| +24% | +$3.78M | 0.22% | 97 |
|
|
2021
Q2 | $14.6M | Buy |
2,147,400
+323,800
| +18% | +$2.2M | 0.15% | 108 |
|
|
2021
Q1 | $18.7M | Buy |
+1,823,600
| New | +$18.7M | 0.18% | 100 |
|